These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1330 related articles for article (PubMed ID: 26291816)
21. [Effect of abdominal acupuncture therapy on the endocrine and metabolism in obesity-type polycystic ovarian syndrome patients]. Lai MH; Ma HX; Yao H; Liu H; Song XH; Huang WY; Wu XK Zhen Ci Yan Jiu; 2010 Aug; 35(4):298-302. PubMed ID: 21090334 [TBL] [Abstract][Full Text] [Related]
22. Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators. Li XL; Ji YF; Feng Y; Liu SW Gynecol Endocrinol; 2024 Dec; 40(1):2312895. PubMed ID: 38444321 [TBL] [Abstract][Full Text] [Related]
23. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome. Zhang YF; Yang YS; Hong J; Gu WQ; Shen CF; Xu M; Du PF; Li XY; Ning G Endocrine; 2006 Jun; 29(3):419-23. PubMed ID: 16943580 [TBL] [Abstract][Full Text] [Related]
24. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances. Olszanecka-Glinianowicz M; Madej P; Nylec M; Owczarek A; Szanecki W; Skałba P; Chudek J Clin Endocrinol (Oxf); 2013 Aug; 79(2):238-42. PubMed ID: 23199261 [TBL] [Abstract][Full Text] [Related]
25. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560 [TBL] [Abstract][Full Text] [Related]
26. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related]
27. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507 [TBL] [Abstract][Full Text] [Related]
28. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome]. Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620 [TBL] [Abstract][Full Text] [Related]
29. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome. Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562 [TBL] [Abstract][Full Text] [Related]
30. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS. Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339 [TBL] [Abstract][Full Text] [Related]
31. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome. Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320 [TBL] [Abstract][Full Text] [Related]
32. Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome. Abruzzese GA; Gamez J; Belli SH; Levalle OA; Mormandi E; Otero P; Graffigna MN; Cerrone GE; Motta AB Gynecol Endocrinol; 2020 Dec; 36(12):1057-1061. PubMed ID: 32496833 [TBL] [Abstract][Full Text] [Related]
33. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Chapman IM; Wittert GA; Norman RJ Clin Endocrinol (Oxf); 1997 Feb; 46(2):175-81. PubMed ID: 9135699 [TBL] [Abstract][Full Text] [Related]
34. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents. Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281 [TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552 [TBL] [Abstract][Full Text] [Related]
36. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome. Sam S; Scoccia B; Yalamanchi S; Mazzone T Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311 [TBL] [Abstract][Full Text] [Related]
37. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance]. Wan DH; Fan P; Bai H; Song Q; Liu HW Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923 [TBL] [Abstract][Full Text] [Related]
38. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. Durmus U; Duran C; Ecirli S J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846 [TBL] [Abstract][Full Text] [Related]
39. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS). Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073 [TBL] [Abstract][Full Text] [Related]
40. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome. Güneş M; Bukan N Gynecol Endocrinol; 2015; 31(11):903-6. PubMed ID: 26291814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]